Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health
Healthcare Communications | Pharmaceutical Executive | Medical Executive | Tech PR | Scientific Executive
Latest Jobs
Exclusive vacancies may not be shown here, please contact Morag on +44 1494 818 018 or for more information.
Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
Morag Shea
Scotland Manager
+44 1494 818 018

I am writing to thank Zenopa for their hard work in securing me with my new position. Zenopa first phoned me and asked questions as to what I was looking for such as type and size of company.
Penny, 2014

Merck Millipore and Proteomics International to ally on biomarker research

1 February 2012 00:00 in Scientific Company News

Merck Millipore has announced a new collaboration with Proteomics International to study biomarkers related to diabetic nephropathy.

The alliance will see Proteomics International assessing thirteen newly identified putative protein biomarkers using multiplex immunoassays from Merck Millipore, including proteins involved in metabolism, inflammation and oxidative stress.

Diabetic nephropathy is a potentially significant complication of diabetes that can lead to kidney failure, but screening for the condition is currently limited to use of the microalbumin test, which offers only limited efficacy.

The new biomarkers could be used to monitor the progression and prognosis of kidney disease in patients with diabetes far more effectively than is now possible.

Dr Jehangir Mistry, director of research and development at Merck Millipore, said: "We expect this opportunity will enable Merck Millipore to expand our substantial portfolio of Elisa and Milliplex multiplexed-bead based assays for diabetes and metabolic disease biomarkers."

In December 2011, the company expanded its product range with the launch of the SIRTainty Class III HDAC Assay, for use in the detection of sirtuin activity.ADNFCR-8000103-ID-801281135-ADNFCR

Other news stories from 01/02/2012

Related news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Axonn News Agency

© Copyright 2015 Zenopa Ltd